ZK-Epo

unknown · Bayer

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ZK-Epo, covering 2021-04-08 to 2021-04-08. Get the full timeline:

Most recent: Clinical Trial Update: ZK-Epo Given With Carboplatin in Patients With Recurrent Ovarian Cancer [Phase 2]